ALBO - Albireo Pharma's (ALBO) CEO Ron Cooper on Q4 2021 Results - Earnings Call Transcript

Albireo Pharma, Inc. (ALBO) Q4 2021 Earnings Conference Call March 1, 2022 10:00 AM ET Company Participants Paul Arndt – Managing Director-LifeSci Advisors, LLC Ron Cooper – President and Chief Executive Officer Pamela Stephenson – Chief Commercial Officer Simon Harford – Chief Financial Officer Conference Call Participants Eun Yang – Jefferies Ritu Baral – Cowen Brian Skorney – Baird Tim Lugo – William Blair Ed Arce – H.C. Wainwright Andreas Argyrides – Wedbush Securities Presentation Operator Good morning, and welcome to the Albireo Pharma, Inc. Fourth Quarter and Year-End 2021 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note that this conference is being recorded. I will now turn the call over to your host, Paul Arndt, Managing Director of LifeSci Advisors. Thank you. You may begin. Paul Arndt Thank you, operator, and good morning,

For further details see:

Albireo Pharma's (ALBO) CEO Ron Cooper on Q4 2021 Results - Earnings Call Transcript